Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Sep 1;174(3):683-92.
doi: 10.1084/jem.174.3.683.

Evidence for clonal selection of gamma/delta T cells in response to a human pathogen

Affiliations

Evidence for clonal selection of gamma/delta T cells in response to a human pathogen

K Uyemura et al. J Exp Med. .

Abstract

T cells bearing gamma/delta antigen receptors comprise a resident population of intraepithelial lymphocytes in organs such as skin, gut, and lungs, where they are strategically located to contribute to the initial defense against infection. An important unsolved question about antigen-driven gamma/delta T cell responses regards the breadth of their T cell receptor (TCR) repertoire, since many specific epithelial compartments in mice display limited diversity. We have examined the diversity of TCR delta gene expression among human gamma/delta T cells from skin lesions induced by intradermal challenge with Mycobacterium leprae. We show that the vast majority of gamma/delta cells from M. leprae lesions use either V delta 1-J delta 1 or V delta 2-J delta 1 gene rearrangements and, within a given region of the lesion, display limited junctional diversity. This contrasts markedly with the extensive diversity of gamma/delta T cells from peripheral blood of these same individuals, as well as skin from normal donors. These results indicate that the gamma/delta response to M. leprae involves the selection of a limited number of clones from among a diverse repertoire, probably in response to specific mycobacterial and/or host antigens.

PubMed Disclaimer

References

    1. Int Immunol. 1989;1(2):176-84 - PubMed
    1. J Infect Dis. 1990 Jul;162(1):283-5 - PubMed
    1. J Exp Med. 1991 Feb 1;173(2):503-6 - PubMed
    1. Int Immunol. 1990;2(8):775-85 - PubMed
    1. Immunol Lett. 1990 Aug;25(1-3):139-41 - PubMed

Publication types

Substances